Breaking News Instant updates and real-time market news.

EYEG

EyeGate

$3.59

-0.31 (-7.95%)

07:00
10/09/19
10/09
07:00
10/09/19
07:00

EyeGate enrolls first patient in follow-on PE pilot study

EyeGate Pharmaceuticals announced that it has enrolled the first patient in its follow-on pilot study for punctate epitheliopathies. The study will use the Ocular Bandage Gel eye drop to treat patients with PE to evaluate several different exploratory performance endpoints. "We are pleased to be underway with this clinical study, as we believe our unique OBG product will be the first approved eye drop in the U.S. for the treatment of PE," said Stephen From, CEO of EyeGate. He continued, "We plan to meet with the U.S. Food and Drug Administration following the data readout to determine the most suitable endpoint to move forward into the pivotal study."

EYEG EyeGate
$3.59

-0.31 (-7.95%)

11/14/18
HCWC
11/14/18
NO CHANGE
Target $6
HCWC
Buy
EyeGate price target raised to $6 from $3 at H.C. Wainwright
H.C. Wainwright analyst Raghuram Selvaraju doubled his price target for EyeGate Pharmaceuticals to $6 citing the company's positive top-line results from two clinical trials of the Ocular Bandage Gel in photorefractive keratectomy surgery and punctate epitheliopathies. The PRK trial demonstrates that Ocular helps heal corneal epithelial defects faster than the standard of care and the PE trial shows that its delivers statistically significant improvement in symptoms due to pathologies such as dry eye, Selvaraju tells investors in a research note. He reiterates a Buy rating on EyeGate.

TODAY'S FREE FLY STORIES

WSFS

WSFS Financial

$44.14

0.02 (0.05%)

16:26
10/21/19
10/21
16:26
10/21/19
16:26
Earnings
WSFS Financial reports Q3 EPS 98c, consensus 87c »

Net interest income in 3Q…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Oct

  • 13

    Nov

QTNT

Quotient

$8.13

-0.33 (-3.90%)

16:25
10/21/19
10/21
16:25
10/21/19
16:25
Conference/Events
Quotient management to meet with Jefferies »

Meeting to be held in New…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Oct

  • 25

    Oct

  • 04

    Nov

HXL

Hexcel

$74.60

-1.61 (-2.11%)

, BA

Boeing

$331.09

-13 (-3.78%)

16:25
10/21/19
10/21
16:25
10/21/19
16:25
Hot Stocks
Hexcel CEO sees further uncertainty related to Boeing 737 Max return to service »

CEO Nick Stanage states:…

HXL

Hexcel

$74.60

-1.61 (-2.11%)

BA

Boeing

$331.09

-13 (-3.78%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Oct

  • 23

    Oct

XAIR

Beyond Air

$4.32

(0.00%)

16:25
10/21/19
10/21
16:25
10/21/19
16:25
Initiation
Beyond Air initiated  »

Oppenheimer starts Beyond…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

IRTC

iRhythm

$66.11

-3.22 (-4.64%)

16:25
10/21/19
10/21
16:25
10/21/19
16:25
Initiation
iRhythm initiated  »

iRhythm initiated with a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

HXL

Hexcel

$74.60

-1.61 (-2.11%)

16:24
10/21/19
10/21
16:24
10/21/19
16:24
Hot Stocks
Hexcel reports Q3 gross margin 27.6% vs. $26.5% last year »

Reports Q3 operating…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Oct

VCYT

Veracyte

$26.18

1.52 (6.16%)

16:23
10/21/19
10/21
16:23
10/21/19
16:23
Hot Stocks
Veracyte says Percepta GSC clinical data results 'inconclusive' »

Veracyte announced data…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Oct

  • 12

    Dec

CRVS

Corvus Pharmaceuticals

$3.50

-0.11 (-3.05%)

16:23
10/21/19
10/21
16:23
10/21/19
16:23
Conference/Events
Corvus Pharmaceuticals management to meet with Jefferies »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Oct

  • 29

    Oct

HXL

Hexcel

$74.60

-1.61 (-2.11%)

16:22
10/21/19
10/21
16:22
10/21/19
16:22
Earnings
Hexcel backs FY19 EPS view $3.43-$3.53 , consensus $3.54 »

Backs FY19 free cash flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Oct

AHT

Ashford Hospitality

$2.94

0.01 (0.34%)

, BHR

Braemar Hotels & Resorts

$9.37

0.225 (2.46%)

16:22
10/21/19
10/21
16:22
10/21/19
16:22
Hot Stocks
Braemar Hotels & Resorts declares distribution of shares of Ashford »

Braemar Hotels &…

AHT

Ashford Hospitality

$2.94

0.01 (0.34%)

BHR

Braemar Hotels & Resorts

$9.37

0.225 (2.46%)

AINC

Ashford

$22.33

-0.13 (-0.58%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Oct

  • 30

    Oct

  • 31

    Oct

  • 31

    Oct

  • 12

    Nov

VREX

Varex Imaging

$29.17

0.45 (1.57%)

16:22
10/21/19
10/21
16:22
10/21/19
16:22
Initiation
Varex Imaging initiated  »

Oppenheimer starts Varex…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CRY

CryoLife

$24.00

0.32 (1.35%)

16:22
10/21/19
10/21
16:22
10/21/19
16:22
Initiation
CryoLife initiated  »

CryoLife initiated with…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 30

    Oct

SITC

Site Centers

$15.26

0.165 (1.09%)

16:22
10/21/19
10/21
16:22
10/21/19
16:22
Syndicate
Site Centers files to sell 10.5M shares of common stock »

Goldman Sachs and Morgan…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 30

    Oct

  • 11

    Nov

  • 12

    Nov

HXL

Hexcel

$74.60

-1.61 (-2.11%)

16:22
10/21/19
10/21
16:22
10/21/19
16:22
Earnings
Hexcel cuts FY19 revenue view to $2.34B-$2.40B from $2.38B-$2.48B 

Consensus $2.43B.

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Oct

FCX

Freeport McMoRan

$9.82

0.245 (2.56%)

, T

AT&T

$38.23

-0.23 (-0.60%)

16:21
10/21/19
10/21
16:21
10/21/19
16:21
Hot Stocks
Freeport-McMoRan names AT&T CFO to board »

Freeport-McMoRan (FCX)…

FCX

Freeport McMoRan

$9.82

0.245 (2.56%)

T

AT&T

$38.23

-0.23 (-0.60%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Oct

  • 23

    Oct

  • 28

    Oct

  • 29

    Oct

  • 18

    Nov

  • 19

    Nov

HXL

Hexcel

$74.60

-1.61 (-2.11%)

16:21
10/21/19
10/21
16:21
10/21/19
16:21
Earnings
Hexcel reports Q3 EPS 90c, consensus 88c »

Reports Q3 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Oct

SITC

Site Centers

$15.26

0.165 (1.09%)

16:20
10/21/19
10/21
16:20
10/21/19
16:20
Earnings
Site Centers reports preliminary Q3 OFF 30c, consensus 28c »

Estimates 1.6% same store…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 30

    Oct

  • 11

    Nov

  • 12

    Nov

KDMN

Kadmon

$3.08

0.17 (5.84%)

16:20
10/21/19
10/21
16:20
10/21/19
16:20
Hot Stocks
Kadmon announces FDA approval for Clovique »

Kadmon announced that the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

VRAY

ViewRay

$2.50

-0.02 (-0.80%)

16:20
10/21/19
10/21
16:20
10/21/19
16:20
Initiation
ViewRay initiated  »

Oppenheimer starts…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Nov

VIX

Volatility Index S&P 500 Options

$0.00

(0.00%)

16:20
10/21/19
10/21
16:20
10/21/19
16:20
Options
Closing CBOE SPX and VIX Index summary for October 21st »

The CBOE Volatility Index…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

VRTX

Vertex

$183.73

7.49 (4.25%)

16:20
10/21/19
10/21
16:20
10/21/19
16:20
Hot Stocks
Breaking Hot Stocks news story on Vertex 

Vertex trading resumes

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Mar

FBP

First BanCorp

$10.24

-0.01 (-0.10%)

16:19
10/21/19
10/21
16:19
10/21/19
16:19
Hot Stocks
First BanCorp to acquire FirstBank Puerto Rico for $425M »

First BanCorp announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Oct

  • 13

    Nov

ACC

American Campus

$49.60

0.44 (0.90%)

16:18
10/21/19
10/21
16:18
10/21/19
16:18
Earnings
American Campus narrows FY19 FFOM view to $2.40-$2.44 from $2.35-$2.45 

Consensus $2.42.

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Oct

  • 12

    Nov

GIFI

Gulf Island Fabrication

$5.63

0.045 (0.81%)

16:18
10/21/19
10/21
16:18
10/21/19
16:18
Hot Stocks
Gulf Island Fabrication CEO Kirk Meche to retire »

Gulf Island Fabrication…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    Nov

ACC

American Campus

$49.60

0.44 (0.90%)

16:17
10/21/19
10/21
16:17
10/21/19
16:17
Earnings
American Campus Communities reports Q3 FFOM 46c, consensus 46c »

Reports Q3 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Oct

  • 12

    Nov

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.